rs1131454
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_016816.4(OAS1):c.484G>A(p.Gly162Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.56 in 1,612,274 control chromosomes in the GnomAD database, including 259,474 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_016816.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.486 AC: 73719AN: 151706Hom.: 20085 Cov.: 30
GnomAD3 exomes AF: 0.569 AC: 142536AN: 250300Hom.: 42483 AF XY: 0.571 AC XY: 77277AN XY: 135218
GnomAD4 exome AF: 0.567 AC: 828699AN: 1460450Hom.: 239378 Cov.: 43 AF XY: 0.568 AC XY: 412896AN XY: 726498
GnomAD4 genome AF: 0.486 AC: 73751AN: 151824Hom.: 20096 Cov.: 30 AF XY: 0.494 AC XY: 36626AN XY: 74184
ClinVar
Submissions by phenotype
not provided Benign:3
- -
- -
This variant is associated with the following publications: (PMID: 16014697) -
OAS1 polymorphism Uncertain:1
- -
not specified Benign:1
This variant is classified as Benign based on local population frequency. This variant was detected in 87% of patients studied by a panel of primary immunodeficiencies. Number of patients: 83. Only high quality variants are reported. -
OAS1-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at